CIK 0001082554 · Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521984749
- Phone
- 3016089292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $342,898,837
- in 74 filings, $342.1M under 10b5-1 plans
Net −$342,898,837. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-27 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,338 | $524.80 | $702K | 44,955 |
| 2026-03-27 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −104 | $526.27 | $55K | 44,851 |
| 2026-03-27 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −314 | $527.30 | $166K | 44,537 |
| 2026-03-27 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −326 | $528.30 | $172K | 44,211 |
| 2026-03-27 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −841 | $529.09 | $445K | 43,370 |
| 2026-03-27 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −903 | $530.45 | $479K | 42,467 |
| 2026-03-27 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −634 | $531.32 | $337K | 41,833 |
| 2026-03-27 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −720 | $532.50 | $383K | 41,113 |
| 2026-03-27 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −440 | $533.85 | $235K | 40,673 |
| 2026-03-27 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −160 | $534.50 | $86K | 40,513 |
| 2026-03-27 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Option 10b5-1 | −9,500 | 50,000 | ||
| 2026-03-26 | EDGEMOND JAMES CFO AND TREASURER | Option exercise 10b5-1 | +10,000 | $135.42 | $1.4M | 28,876 |
| 2026-03-26 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −991 | $532.02 | $527K | 27,885 |
| 2026-03-26 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −510 | $532.93 | $272K | 27,375 |
| 2026-03-26 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −609 | $533.91 | $325K | 26,766 |
| 2026-03-26 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −1,847 | $534.98 | $988K | 24,919 |
| 2026-03-26 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −2,003 | $535.94 | $1.1M | 22,916 |
| 2026-03-26 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −1,577 | $536.90 | $847K | 21,339 |
| 2026-03-26 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −1,149 | $537.90 | $618K | 20,190 |
| 2026-03-26 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −994 | $538.91 | $536K | 19,196 |
Page 138 of 171 · 3,408 trades